Skip to content

Elanco Animal Health

US · ELAN #1381 by market cap Listed 2018
25.74 -0.55 -2.09%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 26.14 -0.57%
After-hours 25.22 -2.04%
26.8421.7725.742026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ELAN?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +15.2% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 6.6% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall D+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation D

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 256.8x Better than 1%
Price / Sales 2.6x Better than 48%
Growth C

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 2.2% Better than 36%
Free cash flow CAGR (3Y) 2.0% Better than 41%
Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 55.0% Better than 69%
Operating margin 5.3% Better than 36%
Net margin -4.9% Better than 19%
Return on equity -3.7% Better than 24%
Return on invested capital -0.7% Better than 27%
Momentum A-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 7.4% Better than 87%
6-month return 18.5% Better than 81%
12-month return (ex latest month) 2.0% Better than 35%
Distance below 52-week high 8.0% Better than 88%
Financial Health C

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.2x Better than 60%
Debt to assets 30.1% Better than 41%
Interest coverage 0.0x Better than 24%
Free cash flow / net income 112.4% Better than 47%
Analyst View B-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 81.8% Better than 62%
Upside to average target 20.1% Better than 33%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -3.88%
1M +13.39%
3M +9.25%
6M +23.45%
YTD +13.74%
1Y +21.19%
3Y +116.67%
5Y -19.84%

Key statistics

Price & volume

Prev close
26.29
Open
26.22
Day range
25.58 - 26.93
Avg price
25.87
Volume
5.83M
Turnover
150.90M
Amplitude
5.15%
52-week range
19.40 - 27.98

Valuation

P/E
-54.77
P/E (TTM)
-85.80
P/B
1.94
EPS
-0.47
Net profit
-234.92M
Net assets
6.63B

Share structure

Market cap
12.87B
Float cap
12.76B
Shares out
499.83M
Float shares
495.70M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2018-09-21
52-week range 74% of range
19.40 27.98

8.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-2.71M net over the window

Short interest

Shares short
32.92M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Elanco Animal Health (ELAN)?

Elanco Animal Health last traded at 25.74. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Elanco Animal Health's market cap?

About 12.87B.

What is the P/E ratio of Elanco Animal Health?

The trailing twelve-month P/E is -85.80. The Valuation tab shows it against the stock's own five-year range.

Does Elanco Animal Health pay a dividend?

Elanco Animal Health does not currently pay a regular dividend.

Is Elanco Animal Health a buy according to analysts?

The consensus of 11 analysts is a Buy rating, with an average 12-month price target of 30.91, which implies 20.1% upside from the current price. This is not investment advice.

What is Elanco Animal Health's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Elanco Animal Health a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.

Elanco Animal Health discussion 0 comments

Add a comment